Division of Clinical and Molecular Endocrinology, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, OH, 44106, USA.
Department of Neurological Surgery, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, OH, 44106, USA.
Pituitary. 2017 Aug;20(4):471-476. doi: 10.1007/s11102-017-0809-7.
Silent corticotroph adenomas (SCAs) are characterized by strong ACTH immunostaining without clinical manifestations of hypercortisolism. Patients with SCAs often present with mechanical symptoms related to tumor growth. This study investigates the hypothalamic pituitary adrenal axis (HPA) characteristics after adenomectomy in patients with SCAs.
Biochemical parameters of HPA function were monitored frequently after surgical resection of non-functioning macroadenomas. Levels of ACTH, cortisol, DHEA and DHEA-S were measured frequently for 48 h after adenomectomy. HPA data of patients with SCAs (n = 38) were compared to others (Controls) with non-secreting, ACTH-negative immunostaining adenomas of similar age and gender distribution (n = 182) who had adenomectomy.
Plasma ACTH increased (P < 0.0001) equally in patients with SCA and controls reaching a peak at 3 h (238 ± 123 vs. 233 ± 96 ng/L, respectively) after extubation declining thereafter to baseline values 24-36 h. Similarly, serum cortisol levels increased (P < 0.0001) equally in both groups reaching a maximum at 7 h (36.8 ± 13.9 vs. 39.3 ± 13.3 ug/dL). Serum DHEA also increased (P < 0.001) equally in both groups in parallel to the rise in serum cortisol. Serum DHEA-S levels similarly increased (P < 0.001) from their respective baseline (105.9 ± 67.5 and 106.5 ± 58.7 ug/dL) reaching their peak (154.5 ± 69.5 and 153.5 ± 68.6 ug/dL; respectively) at 15 h after extubation. None of the patients acquired any hormone deficits.
Under the maximal stimulation of the peri-operative stress, HPA function in patients with SCA behaved in an identical manner to others with ACTH-negative macroadenomas. Thus, despite the strong ACTH-positive immunostaining of these tumors, SCAs are truly non- functional.
静默性促肾上腺皮质激素腺瘤(SCAs)的特点是 ACTH 免疫染色强,但无皮质醇增多症的临床表现。SCA 患者常出现与肿瘤生长相关的机械症状。本研究旨在探讨 SCA 患者经腺瘤切除术治疗后下丘脑-垂体-肾上腺轴(HPA)的特征。
对无功能大腺瘤切除术患者的 HPA 功能生化参数进行频繁监测。在腺瘤切除术后 48 小时内频繁测量 ACTH、皮质醇、DHEA 和 DHEA-S 的水平。将 38 例 SCA 患者(SCA 组)的 HPA 数据与具有相似年龄和性别分布的无分泌、ACTH 阴性免疫染色腺瘤(对照组,n=182)的 HPA 数据进行比较,这些患者也接受了腺瘤切除术。
SCA 组和对照组患者的血浆 ACTH 水平均升高(P<0.0001),拔管后 3 小时达到峰值(分别为 238±123 比 233±96ng/L),此后 24-36 小时降至基线值。同样,两组患者的血清皮质醇水平均升高(P<0.0001),7 小时达到最大值(分别为 36.8±13.9 比 39.3±13.3μg/dL)。血清 DHEA 也同样升高(P<0.001),与血清皮质醇的升高平行。血清 DHEA-S 水平也同样升高(P<0.001),从各自的基线水平(分别为 105.9±67.5 和 106.5±58.7μg/dL),在拔管后 15 小时达到峰值(分别为 154.5±69.5 和 153.5±68.6μg/dL)。无一例患者出现任何激素缺乏。
在围手术期应激的最大刺激下,SCA 患者的 HPA 功能与其他 ACTH 阴性大腺瘤患者的行为方式相同。因此,尽管这些肿瘤的 ACTH 免疫染色强,但 SCA 实际上是无功能的。